Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 10/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.39 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.39 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25992018 | 0.90 | ADORA1 (0.43) | ADORA2AADORA1ADORA2B | |
| SCHEMBL25992015 | 0.88 | ADORA1 (0.41) | GRM5ADORA2AADORA1ADORA2B | |
| SCHEMBL25991989 | 0.80 | ADORA1 (0.38) | GRM5ADORA2AADORA1ADORA2B | |
| SCHEMBL25991965 | 0.79 | TRPV4 (0.45) | GRM5ADORA2AADORA1ADORA2B | |
| SCHEMBL25992384 | 0.79 | XDH (0.46) | GRM5ADORA2AADORA1ADORA2B | |
| SCHEMBL13606452 | 0.75 | GRM5 (0.53) | GRM5KCNH2MAP4K4 | |
| SCHEMBL26633008 | 0.74 | ADORA1 (0.56) | ADORA2AADORA1ADORA2BMAP4K4 | |
| SCHEMBL56741 | 0.69 | GRM5 (0.43) | GRM5 | |
| SCHEMBL1421650 | 0.69 | GRM5 (0.47) | GRM5 | |
| SCHEMBL25992004 | 0.68 | TRPV4 (0.36) | ADORA2AADORA1ADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230263053-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2023-08-17 | — | — | US | disclosed |
| US-20230263053-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2023-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230263053-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | PPOX, CRY1, CRY2 | GRM5 3480/4885KCNH2 749/4885ADORA2A 1718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.